V. Valdespino

Cervical cancer screening: state of the art

Victor M Valdespino, Victor E Valdespino, Victor E. Valdespino, 2006, Current opinion in obstetrics & gynecology.

Cervical secretory immunoglobulin A to human papillomavirus type 16 (HPV16) from HPV16-infected women inhibit HPV16 virus-like particles-induced hemagglutination of mouse red blood cells.

L. Rocha-Zavaleta, A. García-Carrancá, V. Valdespino, 2001, FEMS immunology and medical microbiology.

Molecular pathogenesis of CLL and its evolution

Víctor Quesada, Carlos López-Otín, Elias Campo, 2015, International Journal of Hematology.

Main Phenotype Subphases in Reprogramming Somatic Cells as a Model of Cellular Differentiation Process

V. Valdespino, Patricia M Valdespino, Victor Valdespino Junio, 2013 .

Current perspectives in the treatment of advanced prostate cancer

P. Pisa, P. Tsagozis, V. Valdespino, 2007, Medical oncology.

Genomic-Epigenomic Signaling Pathways Changes in Cellular Differentiation Process

V. Valdespino, Patricia M Valdespino, Victor Valdespino Junior, 2013 .

Potential of epigenetic therapies in the management of solid tumors

V. Valdespino, Patricia M Valdespino, 2015, Cancer management and research.

Increasing the Potential Targets and Molecularly Targeted Agent Combinations Against Cancer Cell Proliferation

V. E. Valdespino-Castillo, P. Valdespino-Castillo, V. Valdespino, 2017 .

Molecular Evaluation of the Prevalence of Oncogenic Human Papillomavirus Genotypes in Cervical Acetowhite Lesions

L. Rocha-Zavaleta, A. García-Carrancá, V. Valdespino, 2002, Intervirology.

Potential of epigenetic therapies in the management of solid tumors

V. Valdespino, Patricia M Valdespino, 2015, Cancer management and research.